Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 4/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | ALPL | P05186 | 1/20 | 0.39 |
| ▸ | ALPI | P09923 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | PIM1 | P11309 | 1/20 | 0.38 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.38 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | F3 | P13726 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrogen Peroxide SCHEMBL29033947 | 0.84 | GSK3B (0.49) | LMNAHPGDMAPTMEN1KMT2A | |
| SCHEMBL132172 | 0.81 | GSK3B (0.50) | LMNAHPGDMAPTMEN1KMT2A | |
| SCHEMBL132173 | 0.81 | GSK3B (0.50) | LMNAHPGDMAPTMEN1KMT2A | |
| SCHEMBL16111885 | 0.78 | MAPT (0.54) | LMNAMAPK1SMN1; SMN2HPGDMAPT | |
| SCHEMBL128473 | 0.71 | MAPT (0.50) | LMNASMN1; SMN2HPGDMAPTMEN1 | |
| SCHEMBL5003596 | 0.71 | MAPT (0.50) | LMNASMN1; SMN2HPGDMAPTMEN1 | |
| SCHEMBL128472 | 0.71 | MAPT (0.50) | LMNASMN1; SMN2HPGDMAPTMEN1 | |
| SCHEMBL15954810 | 0.70 | LRRK2 (0.38) | MAPTMEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL11851323 | 0.69 | LMNA (0.50) | LMNAMAPK1SMN1; SMN2HSD17B10HPGD | |
| SCHEMBL11851316 | 0.69 | LMNA (0.50) | LMNAMAPK1SMN1; SMN2HSD17B10HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10598667-B2 | Functional illumination in living cells | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-03-24 | — | — | US | claimed |
| US-20160313341-A1 | FUNCTIONAL ILLUMINATION IN LIVING CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2016-10-27 | — | — | US | claimed |
| WO-2014160752-A2 | FUNCTIONAL ILLUMINATION IN LIVING CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-10-02 | — | — | WO | claimed |
| WO-2024211779-A1 | AFFINITY PEPTIDES FOR DIAGNOSIS AND TREATMENT OF VIRAL INFECTIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-10-10 | — | — | WO | disclosed |
| US-11629131-B2 | Coupled recognition/detection system for in vivo and in vitro use | CORNELL UNIVERSITY (US) | 2023-04-18 | — | — | US | disclosed |
| US-20220387633-A1 | SMART PEPTIDES AND TRANSFORMABLE NANOPARTICLES FOR CANCER IMMUNOTHERAPY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-12-08 | — | — | US | disclosed |
| EP-4013460-A2 | SMART PEPTIDES AND TRANSFORMABLE NANOPARTICLES FOR CANCER IMMUNOTHERAPY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-06-22 | — | — | EP | disclosed |
| WO-2021030743-A2 | SMART PEPTIDES AND TRANSFORMABLE NANOPARTICLES FOR CANCER IMMUNOTHERAPY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-02-18 | — | — | WO | disclosed |
| US-10598667-B2 | Functional illumination in living cells | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-03-24 | — | — | US | disclosed |
| US-20190185434-A1 | COUPLED RECOGNITION/DETECTION SYSTEM FOR IN VIVO AND IN VITRO USE | UNIV CORNELL (US) | 2019-06-20 | — | — | US | disclosed |
| US-10316000-B2 | Coupled recognition/detection system for in vivo and in vitro use | CORNELL UNIVERSITY (US) | 2019-06-11 | — | — | US | disclosed |
| EP-2398775-B1 | COUPLED RECOGNITION/DETECTION SYSTEM FOR IN VIVO AND IN VITRO USE | UNIV CORNELL (US) | 2019-04-24 | — | — | EP | disclosed |
| US-20160313341-A1 | FUNCTIONAL ILLUMINATION IN LIVING CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2016-10-27 | — | — | US | disclosed |
| WO-2014160752-A2 | FUNCTIONAL ILLUMINATION IN LIVING CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-10-02 | — | — | WO | disclosed |
| US-20120252699-A1 | COUPLED RECOGNITION/DETECTION SYSTEM FOR IN VIVO AND IN VITRO USE | CORNELL UNIVERSITY (US) | 2012-10-04 | — | — | US | disclosed |
| EP-2398775-A1 | COUPLED RECOGNITION/DETECTION SYSTEM FOR IN VIVO AND IN VITRO USE | Cornell University (US) | 2011-12-28 | — | — | EP | disclosed |
| WO-2010096584-A1 | COUPLED RECOGNITION/DETECTION SYSTEM FOR IN VIVO AND IN VITRO USE | CORNELL UNIVERSITY (US) | 2010-08-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220387633-A1 | SMART PEPTIDES AND TRANSFORMABLE NANOPARTICLES FOR CANCER IMMUNOTHERAPY | ERBB2, FOLR2, EGFR | LMNA 1549/4885MAPK1 2237/4885SMN1; SMN2 3728/4885 |
| US-11629131-B2 | Coupled recognition/detection system for in vivo and in vitro use | DCLRE1B, TLR9, APEX1 | LMNA 654/4885MAPK1 3640/4885SMN1; SMN2 4021/4885 |
| US-10316000-B2 | Coupled recognition/detection system for in vivo and in vitro use | DCLRE1B, TLR9, APEX1 | LMNA 654/4885MAPK1 3640/4885SMN1; SMN2 4021/4885 |
| US-20120252699-A1 | COUPLED RECOGNITION/DETECTION SYSTEM FOR IN VIVO AND IN VITRO USE | DCLRE1B, TLR9, APEX1 | LMNA 654/4885MAPK1 3640/4885SMN1; SMN2 4021/4885 |
| US-20190185434-A1 | COUPLED RECOGNITION/DETECTION SYSTEM FOR IN VIVO AND IN VITRO USE | DCLRE1B, TLR9, APEX1 | LMNA 654/4885MAPK1 3640/4885SMN1; SMN2 4021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.